Navigation Links
As the life science industry evolves, it is clear that biologics are here to stay!
Date:3/22/2013

San Francisco, CA (PRWEB) March 22, 2013

Cold Chain IQ, a division of IQPC, announces the BioLogistics Summit, being held June 3-5, 2013 at the Golden Gateway Hotel in San Francisco, CA. This 2 track event will focus on maintaining a regulatory compliant transportation and management of biological materials, clinical specimens and infectious substances.

Want better biologitics? What is the weakest link in cold chain supply? Will cloud computing revolutionize the biopharmaceutical supply chain? In a recent interview, Carlos Castro, Global Transportation and Logistics, Bayer Healthcare, discusses the importance of quality biologistics, key regulatory and operation considerations for cold chain supply and future trends in global pharmaceutical logistics. Listen to the interview entirely here.

Industry leaders from the likes of Pfizer, Baxter, Genentech, and Novartis will offer insights and best practice strategies on the latest developments and updates affecting:
•CMO/CRO Collaboration & Partnerships
•e-Pedigree & Serialization
•Clinical Trial Materials Stability Studies
•Cold Chain Risk Management Processes
•Used Medical Device Returns
•IATA: Perishable Cargo Regulations (PCR)
•Cryo Vessels Transport & Shipping Systems
•Biological Specimens

For more information on the BioLogistics Summit please visit http://www.ColdChainBioLogistics.com or contact Claudia Rubino, Senior Program Director at Claudia.Rubino(at)iqpc(dot)com.

About IQPC
IQPC is an industry-recognized leader in B2B temperature control pharmaceutical events for 12 years across the North America and the world in new and emerging markets. Today there are 13 IQPC cold chain pharmaceutical events around the world. The flagship IQPC Cold Chain Global Forum each September brings 600+ supply chain stakeholders together to discuss today’s hottest topics in temperature control logistics and quality management. Online we continue engaging and educating the temperature control biopharma industry on http://www.coldchainiq.com – a free resource center of articles, videos and expert interviews.

Contact:
IQPC
Taryn Soltysiak
Marketing Manager
E: taryn.soltysiak(at)iqpc(dot)com
T: +1 212-885-2695
http://www.ColdChainBioLogistics.com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10558145.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
2. Iowa Educator Receives DuPont AgriSCIENCE Award for Teaching Excellence
3. A “Fail Fast” Strategy for Lead Optimization Pharmacology and Toxicology, New Xtalks Life Sciences Webinar
4. The BioVoyage Institute is seeking the help of corporations, organizations, institutions, communities and individuals to help with bioscience and biotechnology education
5. The #1 Science Fiction Novel of 2011 (and NY Times Bestseller) Now Only $5.95
6. BioMed Realty To Lease 204,900 Square Feet To Life Technologies At The Science Center at Oyster Point In South San Francisco
7. Regulatory Affairs: The Key to Russia, New Life Science Webinar Hosted by Xtalks
8. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
9. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
10. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
11. Lockheed Martin to Continue Providing Life Sciences Support to NASA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , a ... Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out from ... and clinical applications. The terms of the transaction were not disclosed. , ...
(Date:2/22/2017)... ... 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), ... today announced it has issued a scientific white paper entitled “Results from recent ... of commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017 Aethlon ... the results of a study that validated the ability ... that are associated with increased mortality in immune-suppressed sepsis ... patients. The objective of the study ... of Cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Herpes Simplex ...
(Date:2/21/2017)... ROCKVILLE, Md. , Feb. 21, 2017 Synthetic ... therapeutics designed to preserve the microbiome to protect and restore the ... for the year ended December 31, 2016 on Thursday, March 2, ... 4:30 p.m. EST. The dial-in information for the call is as ... ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
Breaking Biology News(10 mins):